{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-011176","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2025-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.482755+00:00","generated_at":"2026-05-21T03:25:08.253589+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"INBS surpasses 450 accounts; expands fingerprint drug testing into luxury marine, retail, and waste sectors","bullets":["Over 450 active accounts globally, with 35 new accounts added in fiscal Q3.","Expanded into luxury marine sector in Europe, retail (major e-commerce) and waste/recycling in Australia.","Distributor network now includes 18 partners across 19 countries for localized support.","Plans to introduce a collected testing service to provide flexibility for high-volume customers."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-011176","json":"https://secwatch.observer/filing/0001641172-25-011176.json","markdown":"https://secwatch.observer/filing/0001641172-25-011176.md","text":"https://secwatch.observer/filing/0001641172-25-011176.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000164117225011176/0001641172-25-011176-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000164117225011176/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T03:25:08.253589+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}